<DOC>
	<DOCNO>NCT02804750</DOCNO>
	<brief_summary>Cushing 's syndrome relatively rare disorder cause prolonged exposure high level glucocorticoid hormone cortisol . Cushing 's syndrome may result elevate endogenous exogenous source cortisol . Endogenous Cushing 's syndrome result cortisol overproduction adrenal gland subject protocol . Patients exogenous Cushing 's syndrome , develops side effect chronic administration high dos glucocorticoid , eligible enrollment study . The purpose study evaluate safety efficacy CORT125134 treatment endogenous Cushing 's syndrome . The multicenter study conduct United States Europe .</brief_summary>
	<brief_title>Study Evaluate CORT125134 Patients With Cushing 's Syndrome</brief_title>
	<detailed_description>This Phase 2 , open-label study two dose group , two-step dose escalation , design evaluate safety efficacy CORT125134 treatment endogenous Cushing 's syndrome . CORT125134 administer orally daily 12 week dose escalation occur every 4 week . PK profile generate every dose level . A data review committee review PK safety data recommend final plan dose escalation Group 2 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<criteria>1 . Has confirm diagnosis endogenous Cushing 's syndrome . 2 . Requires medical treatment hypercortisolemia . 3 . Meets least one follow criterion : 1 . Has type 2 diabetes mellitus . 2 . Has impair glucose tolerance . 3 . Has hypertension . 1 . Has nonendogenous source hypercortisolemia 2 . Has uncontrolled , clinically significant hypothyroidism hyperthyroidism 3 . Has poorly control hypertension 4 . Has Stage â‰¥ 4 renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Cushing 's Syndrome</keyword>
	<keyword>Cushing 's Disease</keyword>
	<keyword>Cushings</keyword>
	<keyword>Hypercortisolemia</keyword>
	<keyword>Cushingoid</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Impaired Glucose Intolerance</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Adrenal Corticotrophic Hormone ( ACTH )</keyword>
	<keyword>Adrenocortical Carcinoma</keyword>
	<keyword>Primary Pigmented Nodular Adrenal Disease ( PPNAD )</keyword>
	<keyword>Moon Facies</keyword>
	<keyword>Dorsocervical Fat Pad</keyword>
	<keyword>Adrenal Adenoma</keyword>
	<keyword>Adrenal Carcinoma</keyword>
	<keyword>Adrenal Autonomy</keyword>
	<keyword>Cortisol</keyword>
</DOC>